OP Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Buy
16,758
+1,495
+10% +$286K 0.04% 324
2026
Q1
$2.8M Sell
15,263
-983
-6% -$181K 0.03% 369
2025
Q4
$2.86M Sell
16,246
-841
-5% -$137K 0.03% 348
2025
Q3
$2.39M Sell
17,087
-3,761
-18% -$508K 0.03% 399
2025
Q2
$2.62M Buy
20,848
+811
+4% +$101K 0.04% 370
2025
Q1
$2.74M Buy
+20,037
New +$2.86M 0.04% 342

Other funds holding BIIB

OP Asset Management's BIIB Position: Q2 2026 in Review

OP Asset Management increased its Biogen (BIIB) stake by 9.8% in Q2 2026, buying an estimated $286K and bringing the position to 16,758 shares worth $3.62M. The position accounts for 0.04% of the portfolio, ranked #324.

OP Asset Management first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 413 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • OP Asset Management held 16,758 shares of Biogen worth $3.62M as of Q2 2026.
  • OP Asset Management bought 1,495 Biogen shares in Q2 2026, an estimated $286K.
  • Biogen made up 0.04% of OP Asset Management's portfolio in Q2 2026, its #324 holding.
  • OP Asset Management first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 413 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.